Catalyst

Slingshot members are tracking this event:

Phase 2b data of Axovant's(AXON) Intepirdine - HEADWAY-DLB in treating Dementia with Lewy bodies (DLB) January 2018

Source Link:
http://investors.axovant.com/news-releases/news-release-details/axovant-announces-fiscal-first-quarter-financial-results-and

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AXON Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Update on Nov 2 2017: Topline data now expected January 2018
http://investors.axo...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jan 09, 2018
Occurred Source:
http://investors.axovant.com/news-releases/news-release-details/correction-axovant-announces-negative-results-intepirdine-phase
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Intepirdine - Headway-dlb, Dementia, Lewy Bodies
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.